Agios Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
35.15 |
45.11 |
119.59 |
301.07 |
613.67 |
928.23 |
| Przychód Δ r/r |
0.00% |
28.32% |
165.12% |
151.76% |
103.83% |
51.26% |
| Przychód (min) |
34.01 |
38.65 |
95.49 |
299.01 |
517.30 |
782.47 |
| Przychód (max) |
36.47 |
53.44 |
166.38 |
303.12 |
775.41 |
1,172.88 |
| EBITDA (średnia) |
-21.09 |
-27.06 |
-71.75 |
-180.64 |
-368.20 |
-556.94 |
| EBIT (średnia) |
-21.09 |
-27.06 |
-71.75 |
-180.64 |
-368.20 |
-556.94 |
| EBIT % |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
650.08 |
-424.97 |
-430.92 |
-309.60 |
-123.14 |
73.81 |
| Zysk netto % |
1849.31% |
-942.15% |
-360.34% |
-102.83% |
-20.07% |
7.95% |
| EPS (średnia) |
11.44 |
-7.34 |
-7.12 |
-4.86 |
-2.13 |
1.27 |
| Liczba analityków (Przychody) |
7 |
6 |
8 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
6 |
7 |
8 |
7 |
5 |
2 |
| symbol |
AGIO |
AGIO |
AGIO |
AGIO |
AGIO |
AGIO |